These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 30196577

  • 1. Predicting the Onset of Nonlinear Pharmacokinetics.
    Stein AM, Peletier LA.
    CPT Pharmacometrics Syst Pharmacol; 2018 Oct; 7(10):670-677. PubMed ID: 30196577
    [Abstract] [Full Text] [Related]

  • 2. Target-mediated exposure enhancement: a previously unexplored limit of TMDD.
    Glassman PM, Muzykantov VR.
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):411-420. PubMed ID: 32488574
    [Abstract] [Full Text] [Related]

  • 3. Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies.
    Cao Y, Jusko WJ.
    J Pharmacokinet Pharmacodyn; 2014 Aug; 41(4):375-87. PubMed ID: 25077917
    [Abstract] [Full Text] [Related]

  • 4. Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds.
    An G.
    J Clin Pharmacol; 2020 Feb; 60(2):149-163. PubMed ID: 31793004
    [Abstract] [Full Text] [Related]

  • 5. Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models.
    Yan X, Mager DE, Krzyzanski W.
    J Pharmacokinet Pharmacodyn; 2010 Feb; 37(1):25-47. PubMed ID: 20012173
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Explicit solution of integrated 1 - exp equation for predicting accumulation and decline of concentrations for drugs obeying nonlinear saturation kinetics.
    Keller F, Hartmann B, Czock D.
    Ther Drug Monit; 2009 Dec; 31(6):783-5. PubMed ID: 19881403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. General Pharmacokinetic Features of Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Simulation-Based Study.
    Bach T, Jiang Y, Zhang X, An G.
    J Clin Pharmacol; 2019 Mar; 59(3):394-405. PubMed ID: 30387863
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Target-mediated drug disposition and dynamics.
    Mager DE.
    Biochem Pharmacol; 2006 Jun 28; 72(1):1-10. PubMed ID: 16469301
    [Abstract] [Full Text] [Related]

  • 14. Analysis methods and recent advances in nonlinear pharmacokinetics from in vitro through in loci to in vivo.
    Yamaoka K, Takakura Y.
    Drug Metab Pharmacokinet; 2004 Dec 28; 19(6):397-406. PubMed ID: 15681893
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.